Nara Organics has voluntarily recalled its powdered infant formula sold across the United States after three infants were diagnosed with infant botulism, according to the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC). The affected babies, located in California, Washington, and Pennsylvania, were hospitalized but successfully treated with no reported deaths.
What Happened
On June 14, 2026, the FDA issued a notice on the voluntary recall of Nara Organics Powdered Infant Formula after confirmation that three infants who contracted botulism had consumed the product. The formula, sold at Target stores nationwide, as well as online via Target.com and Nara.com, was pulled despite no positive tests for Clostridium botulinum in the product lots. The recall specifically concerns all whole milk infant powdered formula products from Nara.
Key Facts
- The three contaminated product lots are numbered 709125280E14F2, 709125288E14F2, and 708125174E14F2.
- The recalls cover formula sold exclusively in the United States; no international sales have been reported.
- The affected infants were hospitalized in California, Washington, and Pennsylvania but recovered fully.
- Customers who purchased products from Nara.com during May and June 2026 will receive automatic refunds; others can request refunds online.
- Target customers can return the formula to the stores or receive refunds via Target’s website.
Why It Matters
The recall safeguards infants from the potentially fatal neurotoxin produced by Clostridium botulinum, which causes infant botulism. This incident highlights risks in infant nutrition products, impacts consumer trust in organic baby formula markets, and prompts alertness among caregivers and retailers to ensure infant safety.
Background
Infant botulism is caused by ingestion of C. botulinum spores that colonize the infant’s intestine, producing toxins that can lead to severe neurological symptoms and require urgent medical treatment. A previous outbreak linked to another formula brand, ByHeart, caused over 50 infant illnesses across 19 states.
Analysis
Nara Organics stated it is taking aggressive measures and cooperating with FDA, CDC, and state health officials to investigate root causes of the contamination and enhance product safety. The recall is a precautionary step to protect vulnerable consumers while ensuring regulatory partners have full transparency.
Who Is Affected
Infants consuming Nara Organics Powdered Infant Formula—especially products from the specified recalled lots—are directly affected. Retailers including Target, online customers purchasing through Target and Nara websites, and families nationwide are involved in the recall and refund process.
What Remains Unclear
- The exact source or contamination pathway of Clostridium botulinum spores in the formula remains under investigation.
- No positive test results for the bacteria in formula lots have been reported yet.
What Comes Next
Nara Organics will continue working with federal and state health authorities as investigations proceed. Refund processes remain open for affected consumers via Nara.com and Target’s channels. Further updates will follow pending findings from the ongoing safety review.
Sources
This article is based on reporting and publicly available information from the following source:
Read more US News stories on Goka World News.